[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global BCG Vaccine for Intradermal Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

March 2023 | 98 pages | ID: GBC7C61AA967EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global BCG Vaccine for Intradermal Injection market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global BCG Vaccine for Intradermal Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global BCG Vaccine for Intradermal Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global BCG Vaccine for Intradermal Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global BCG Vaccine for Intradermal Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global BCG Vaccine for Intradermal Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for BCG Vaccine for Intradermal Injection

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global BCG Vaccine for Intradermal Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Sanofi Pasteur, Japan BCG Lab, Shanghai Institute of Biological Products and Serum Institute of India, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

BCG Vaccine for Intradermal Injection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
  • BCG for Immunization
  • BCG for Therapy
Market segment by Application
  • Hospital
  • Clinic
  • Other
Major players covered
  • Merck
  • Sanofi Pasteur
  • Japan BCG Lab
  • Shanghai Institute of Biological Products
  • Serum Institute of India
  • Intervax
  • GSBPL
Market segment by region, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe BCG Vaccine for Intradermal Injection product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of BCG Vaccine for Intradermal Injection, with price, sales, revenue and global market share of BCG Vaccine for Intradermal Injection from 2018 to 2023.

Chapter 3, the BCG Vaccine for Intradermal Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the BCG Vaccine for Intradermal Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and BCG Vaccine for Intradermal Injection market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of BCG Vaccine for Intradermal Injection.

Chapter 14 and 15, to describe BCG Vaccine for Intradermal Injection sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of BCG Vaccine for Intradermal Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global BCG Vaccine for Intradermal Injection Consumption Value by Type: 2018 Versus 2022 Versus 2029
  1.3.2 BCG for Immunization
  1.3.3 BCG for Therapy
1.4 Market Analysis by Application
  1.4.1 Overview: Global BCG Vaccine for Intradermal Injection Consumption Value by Application: 2018 Versus 2022 Versus 2029
  1.4.2 Hospital
  1.4.3 Clinic
  1.4.4 Other
1.5 Global BCG Vaccine for Intradermal Injection Market Size & Forecast
  1.5.1 Global BCG Vaccine for Intradermal Injection Consumption Value (2018 & 2022 & 2029)
  1.5.2 Global BCG Vaccine for Intradermal Injection Sales Quantity (2018-2029)
  1.5.3 Global BCG Vaccine for Intradermal Injection Average Price (2018-2029)

2 MANUFACTURERS PROFILES

2.1 Merck
  2.1.1 Merck Details
  2.1.2 Merck Major Business
  2.1.3 Merck BCG Vaccine for Intradermal Injection Product and Services
  2.1.4 Merck BCG Vaccine for Intradermal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.1.5 Merck Recent Developments/Updates
2.2 Sanofi Pasteur
  2.2.1 Sanofi Pasteur Details
  2.2.2 Sanofi Pasteur Major Business
  2.2.3 Sanofi Pasteur BCG Vaccine for Intradermal Injection Product and Services
  2.2.4 Sanofi Pasteur BCG Vaccine for Intradermal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.2.5 Sanofi Pasteur Recent Developments/Updates
2.3 Japan BCG Lab
  2.3.1 Japan BCG Lab Details
  2.3.2 Japan BCG Lab Major Business
  2.3.3 Japan BCG Lab BCG Vaccine for Intradermal Injection Product and Services
  2.3.4 Japan BCG Lab BCG Vaccine for Intradermal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.3.5 Japan BCG Lab Recent Developments/Updates
2.4 Shanghai Institute of Biological Products
  2.4.1 Shanghai Institute of Biological Products Details
  2.4.2 Shanghai Institute of Biological Products Major Business
  2.4.3 Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Product and Services
  2.4.4 Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.4.5 Shanghai Institute of Biological Products Recent Developments/Updates
2.5 Serum Institute of India
  2.5.1 Serum Institute of India Details
  2.5.2 Serum Institute of India Major Business
  2.5.3 Serum Institute of India BCG Vaccine for Intradermal Injection Product and Services
  2.5.4 Serum Institute of India BCG Vaccine for Intradermal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.5.5 Serum Institute of India Recent Developments/Updates
2.6 Intervax
  2.6.1 Intervax Details
  2.6.2 Intervax Major Business
  2.6.3 Intervax BCG Vaccine for Intradermal Injection Product and Services
  2.6.4 Intervax BCG Vaccine for Intradermal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.6.5 Intervax Recent Developments/Updates
2.7 GSBPL
  2.7.1 GSBPL Details
  2.7.2 GSBPL Major Business
  2.7.3 GSBPL BCG Vaccine for Intradermal Injection Product and Services
  2.7.4 GSBPL BCG Vaccine for Intradermal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.7.5 GSBPL Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: BCG VACCINE FOR INTRADERMAL INJECTION BY MANUFACTURER

3.1 Global BCG Vaccine for Intradermal Injection Sales Quantity by Manufacturer (2018-2023)
3.2 Global BCG Vaccine for Intradermal Injection Revenue by Manufacturer (2018-2023)
3.3 Global BCG Vaccine for Intradermal Injection Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
  3.4.1 Producer Shipments of BCG Vaccine for Intradermal Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
  3.4.2 Top 3 BCG Vaccine for Intradermal Injection Manufacturer Market Share in 2022
  3.4.2 Top 6 BCG Vaccine for Intradermal Injection Manufacturer Market Share in 2022
3.5 BCG Vaccine for Intradermal Injection Market: Overall Company Footprint Analysis
  3.5.1 BCG Vaccine for Intradermal Injection Market: Region Footprint
  3.5.2 BCG Vaccine for Intradermal Injection Market: Company Product Type Footprint
  3.5.3 BCG Vaccine for Intradermal Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global BCG Vaccine for Intradermal Injection Market Size by Region
  4.1.1 Global BCG Vaccine for Intradermal Injection Sales Quantity by Region (2018-2029)
  4.1.2 Global BCG Vaccine for Intradermal Injection Consumption Value by Region (2018-2029)
  4.1.3 Global BCG Vaccine for Intradermal Injection Average Price by Region (2018-2029)
4.2 North America BCG Vaccine for Intradermal Injection Consumption Value (2018-2029)
4.3 Europe BCG Vaccine for Intradermal Injection Consumption Value (2018-2029)
4.4 Asia-Pacific BCG Vaccine for Intradermal Injection Consumption Value (2018-2029)
4.5 South America BCG Vaccine for Intradermal Injection Consumption Value (2018-2029)
4.6 Middle East and Africa BCG Vaccine for Intradermal Injection Consumption Value (2018-2029)

5 MARKET SEGMENT BY TYPE

5.1 Global BCG Vaccine for Intradermal Injection Sales Quantity by Type (2018-2029)
5.2 Global BCG Vaccine for Intradermal Injection Consumption Value by Type (2018-2029)
5.3 Global BCG Vaccine for Intradermal Injection Average Price by Type (2018-2029)

6 MARKET SEGMENT BY APPLICATION

6.1 Global BCG Vaccine for Intradermal Injection Sales Quantity by Application (2018-2029)
6.2 Global BCG Vaccine for Intradermal Injection Consumption Value by Application (2018-2029)
6.3 Global BCG Vaccine for Intradermal Injection Average Price by Application (2018-2029)

7 NORTH AMERICA

7.1 North America BCG Vaccine for Intradermal Injection Sales Quantity by Type (2018-2029)
7.2 North America BCG Vaccine for Intradermal Injection Sales Quantity by Application (2018-2029)
7.3 North America BCG Vaccine for Intradermal Injection Market Size by Country
  7.3.1 North America BCG Vaccine for Intradermal Injection Sales Quantity by Country (2018-2029)
  7.3.2 North America BCG Vaccine for Intradermal Injection Consumption Value by Country (2018-2029)
  7.3.3 United States Market Size and Forecast (2018-2029)
  7.3.4 Canada Market Size and Forecast (2018-2029)
  7.3.5 Mexico Market Size and Forecast (2018-2029)

8 EUROPE

8.1 Europe BCG Vaccine for Intradermal Injection Sales Quantity by Type (2018-2029)
8.2 Europe BCG Vaccine for Intradermal Injection Sales Quantity by Application (2018-2029)
8.3 Europe BCG Vaccine for Intradermal Injection Market Size by Country
  8.3.1 Europe BCG Vaccine for Intradermal Injection Sales Quantity by Country (2018-2029)
  8.3.2 Europe BCG Vaccine for Intradermal Injection Consumption Value by Country (2018-2029)
  8.3.3 Germany Market Size and Forecast (2018-2029)
  8.3.4 France Market Size and Forecast (2018-2029)
  8.3.5 United Kingdom Market Size and Forecast (2018-2029)
  8.3.6 Russia Market Size and Forecast (2018-2029)
  8.3.7 Italy Market Size and Forecast (2018-2029)

9 ASIA-PACIFIC

9.1 Asia-Pacific BCG Vaccine for Intradermal Injection Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific BCG Vaccine for Intradermal Injection Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific BCG Vaccine for Intradermal Injection Market Size by Region
  9.3.1 Asia-Pacific BCG Vaccine for Intradermal Injection Sales Quantity by Region (2018-2029)
  9.3.2 Asia-Pacific BCG Vaccine for Intradermal Injection Consumption Value by Region (2018-2029)
  9.3.3 China Market Size and Forecast (2018-2029)
  9.3.4 Japan Market Size and Forecast (2018-2029)
  9.3.5 Korea Market Size and Forecast (2018-2029)
  9.3.6 India Market Size and Forecast (2018-2029)
  9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
  9.3.8 Australia Market Size and Forecast (2018-2029)

10 SOUTH AMERICA

10.1 South America BCG Vaccine for Intradermal Injection Sales Quantity by Type (2018-2029)
10.2 South America BCG Vaccine for Intradermal Injection Sales Quantity by Application (2018-2029)
10.3 South America BCG Vaccine for Intradermal Injection Market Size by Country
  10.3.1 South America BCG Vaccine for Intradermal Injection Sales Quantity by Country (2018-2029)
  10.3.2 South America BCG Vaccine for Intradermal Injection Consumption Value by Country (2018-2029)
  10.3.3 Brazil Market Size and Forecast (2018-2029)
  10.3.4 Argentina Market Size and Forecast (2018-2029)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa BCG Vaccine for Intradermal Injection Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa BCG Vaccine for Intradermal Injection Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa BCG Vaccine for Intradermal Injection Market Size by Country
  11.3.1 Middle East & Africa BCG Vaccine for Intradermal Injection Sales Quantity by Country (2018-2029)
  11.3.2 Middle East & Africa BCG Vaccine for Intradermal Injection Consumption Value by Country (2018-2029)
  11.3.3 Turkey Market Size and Forecast (2018-2029)
  11.3.4 Egypt Market Size and Forecast (2018-2029)
  11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
  11.3.6 South Africa Market Size and Forecast (2018-2029)

12 MARKET DYNAMICS

12.1 BCG Vaccine for Intradermal Injection Market Drivers
12.2 BCG Vaccine for Intradermal Injection Market Restraints
12.3 BCG Vaccine for Intradermal Injection Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
  12.5.1 Influence of COVID-19
  12.5.2 Influence of Russia-Ukraine War

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of BCG Vaccine for Intradermal Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of BCG Vaccine for Intradermal Injection
13.3 BCG Vaccine for Intradermal Injection Production Process
13.4 BCG Vaccine for Intradermal Injection Industrial Chain

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 BCG Vaccine for Intradermal Injection Typical Distributors
14.3 BCG Vaccine for Intradermal Injection Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

LIST OF TABLES

Table 1. Global BCG Vaccine for Intradermal Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global BCG Vaccine for Intradermal Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck BCG Vaccine for Intradermal Injection Product and Services
Table 6. Merck BCG Vaccine for Intradermal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Pasteur Major Business
Table 10. Sanofi Pasteur BCG Vaccine for Intradermal Injection Product and Services
Table 11. Sanofi Pasteur BCG Vaccine for Intradermal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sanofi Pasteur Recent Developments/Updates
Table 13. Japan BCG Lab Basic Information, Manufacturing Base and Competitors
Table 14. Japan BCG Lab Major Business
Table 15. Japan BCG Lab BCG Vaccine for Intradermal Injection Product and Services
Table 16. Japan BCG Lab BCG Vaccine for Intradermal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Japan BCG Lab Recent Developments/Updates
Table 18. Shanghai Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 19. Shanghai Institute of Biological Products Major Business
Table 20. Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Product and Services
Table 21. Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Shanghai Institute of Biological Products Recent Developments/Updates
Table 23. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 24. Serum Institute of India Major Business
Table 25. Serum Institute of India BCG Vaccine for Intradermal Injection Product and Services
Table 26. Serum Institute of India BCG Vaccine for Intradermal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Serum Institute of India Recent Developments/Updates
Table 28. Intervax Basic Information, Manufacturing Base and Competitors
Table 29. Intervax Major Business
Table 30. Intervax BCG Vaccine for Intradermal Injection Product and Services
Table 31. Intervax BCG Vaccine for Intradermal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Intervax Recent Developments/Updates
Table 33. GSBPL Basic Information, Manufacturing Base and Competitors
Table 34. GSBPL Major Business
Table 35. GSBPL BCG Vaccine for Intradermal Injection Product and Services
Table 36. GSBPL BCG Vaccine for Intradermal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. GSBPL Recent Developments/Updates
Table 38. Global BCG Vaccine for Intradermal Injection Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 39. Global BCG Vaccine for Intradermal Injection Revenue by Manufacturer (2018-2023) & (USD Million)
Table 40. Global BCG Vaccine for Intradermal Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 41. Market Position of Manufacturers in BCG Vaccine for Intradermal Injection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 42. Head Office and BCG Vaccine for Intradermal Injection Production Site of Key Manufacturer
Table 43. BCG Vaccine for Intradermal Injection Market: Company Product Type Footprint
Table 44. BCG Vaccine for Intradermal Injection Market: Company Product Application Footprint
Table 45. BCG Vaccine for Intradermal Injection New Market Entrants and Barriers to Market Entry
Table 46. BCG Vaccine for Intradermal Injection Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global BCG Vaccine for Intradermal Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 48. Global BCG Vaccine for Intradermal Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 49. Global BCG Vaccine for Intradermal Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 50. Global BCG Vaccine for Intradermal Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 51. Global BCG Vaccine for Intradermal Injection Average Price by Region (2018-2023) & (US$/Unit)
Table 52. Global BCG Vaccine for Intradermal Injection Average Price by Region (2024-2029) & (US$/Unit)
Table 53. Global BCG Vaccine for Intradermal Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 54. Global BCG Vaccine for Intradermal Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 55. Global BCG Vaccine for Intradermal Injection Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Global BCG Vaccine for Intradermal Injection Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Global BCG Vaccine for Intradermal Injection Average Price by Type (2018-2023) & (US$/Unit)
Table 58. Global BCG Vaccine for Intradermal Injection Average Price by Type (2024-2029) & (US$/Unit)
Table 59. Global BCG Vaccine for Intradermal Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 60. Global BCG Vaccine for Intradermal Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 61. Global BCG Vaccine for Intradermal Injection Consumption Value by Application (2018-2023) & (USD Million)
Table 62. Global BCG Vaccine for Intradermal Injection Consumption Value by Application (2024-2029) & (USD Million)
Table 63. Global BCG Vaccine for Intradermal Injection Average Price by Application (2018-2023) & (US$/Unit)
Table 64. Global BCG Vaccine for Intradermal Injection Average Price by Application (2024-2029) & (US$/Unit)
Table 65. North America BCG Vaccine for Intradermal Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 66. North America BCG Vaccine for Intradermal Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 67. North America BCG Vaccine for Intradermal Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 68. North America BCG Vaccine for Intradermal Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 69. North America BCG Vaccine for Intradermal Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 70. North America BCG Vaccine for Intradermal Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 71. North America BCG Vaccine for Intradermal Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 72. North America BCG Vaccine for Intradermal Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Europe BCG Vaccine for Intradermal Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Europe BCG Vaccine for Intradermal Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Europe BCG Vaccine for Intradermal Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 76. Europe BCG Vaccine for Intradermal Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 77. Europe BCG Vaccine for Intradermal Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 78. Europe BCG Vaccine for Intradermal Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 79. Europe BCG Vaccine for Intradermal Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe BCG Vaccine for Intradermal Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific BCG Vaccine for Intradermal Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 82. Asia-Pacific BCG Vaccine for Intradermal Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 83. Asia-Pacific BCG Vaccine for Intradermal Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 84. Asia-Pacific BCG Vaccine for Intradermal Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 85. Asia-Pacific BCG Vaccine for Intradermal Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 86. Asia-Pacific BCG Vaccine for Intradermal Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 87. Asia-Pacific BCG Vaccine for Intradermal Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 88. Asia-Pacific BCG Vaccine for Intradermal Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 89. South America BCG Vaccine for Intradermal Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 90. South America BCG Vaccine for Intradermal Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 91. South America BCG Vaccine for Intradermal Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 92. South America BCG Vaccine for Intradermal Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 93. South America BCG Vaccine for Intradermal Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 94. South America BCG Vaccine for Intradermal Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 95. South America BCG Vaccine for Intradermal Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 96. South America BCG Vaccine for Intradermal Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 97. Middle East & Africa BCG Vaccine for Intradermal Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 98. Middle East & Africa BCG Vaccine for Intradermal Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 99. Middle East & Africa BCG Vaccine for Intradermal Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Middle East & Africa BCG Vaccine for Intradermal Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Middle East & Africa BCG Vaccine for Intradermal Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 102. Middle East & Africa BCG Vaccine for Intradermal Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 103. Middle East & Africa BCG Vaccine for Intradermal Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 104. Middle East & Africa BCG Vaccine for Intradermal Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 105. BCG Vaccine for Intradermal Injection Raw Material
Table 106. Key Manufacturers of BCG Vaccine for Intradermal Injection Raw Materials
Table 107. BCG Vaccine for Intradermal Injection Typical Distributors
Table 108. BCG Vaccine for Intradermal Injection Typical Customers

LIST OF FIGURES

Figure 1. BCG Vaccine for Intradermal Injection Picture
Figure 2. Global BCG Vaccine for Intradermal Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global BCG Vaccine for Intradermal Injection Consumption Value Market Share by Type in 2022
Figure 4. BCG for Immunization Examples
Figure 5. BCG for Therapy Examples
Figure 6. Global BCG Vaccine for Intradermal Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global BCG Vaccine for Intradermal Injection Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Other Examples
Figure 11. Global BCG Vaccine for Intradermal Injection Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global BCG Vaccine for Intradermal Injection Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global BCG Vaccine for Intradermal Injection Sales Quantity (2018-2029) & (K Units)
Figure 14. Global BCG Vaccine for Intradermal Injection Average Price (2018-2029) & (US$/Unit)
Figure 15. Global BCG Vaccine for Intradermal Injection Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global BCG Vaccine for Intradermal Injection Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of BCG Vaccine for Intradermal Injection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 BCG Vaccine for Intradermal Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 BCG Vaccine for Intradermal Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global BCG Vaccine for Intradermal Injection Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global BCG Vaccine for Intradermal Injection Consumption Value Market Share by Region (2018-2029)
Figure 22. North America BCG Vaccine for Intradermal Injection Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe BCG Vaccine for Intradermal Injection Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific BCG Vaccine for Intradermal Injection Consumption Value (2018-2029) & (USD Million)
Figure 25. South America BCG Vaccine for Intradermal Injection Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa BCG Vaccine for Intradermal Injection Consumption Value (2018-2029) & (USD Million)
Figure 27. Global BCG Vaccine for Intradermal Injection Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global BCG Vaccine for Intradermal Injection Consumption Value Market Share by Type (2018-2029)
Figure 29. Global BCG Vaccine for Intradermal Injection Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global BCG Vaccine for Intradermal Injection Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global BCG Vaccine for Intradermal Injection Consumption Value Market Share by Application (2018-2029)
Figure 32. Global BCG Vaccine for Intradermal Injection Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America BCG Vaccine for Intradermal Injection Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America BCG Vaccine for Intradermal Injection Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America BCG Vaccine for Intradermal Injection Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America BCG Vaccine for Intradermal Injection Consumption Value Market Share by Country (2018-2029)
Figure 37. United States BCG Vaccine for Intradermal Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada BCG Vaccine for Intradermal Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico BCG Vaccine for Intradermal Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe BCG Vaccine for Intradermal Injection Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe BCG Vaccine for Intradermal Injection Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe BCG Vaccine for Intradermal Injection Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe BCG Vaccine for Intradermal Injection Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany BCG Vaccine for Intradermal Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France BCG Vaccine for Intradermal Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom BCG Vaccine for Intradermal Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia BCG Vaccine for Intradermal Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy BCG Vaccine for Intradermal Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific BCG Vaccine for Intradermal Injection Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific BCG Vaccine for Intradermal Injection Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific BCG Vaccine for Intradermal Injection Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific BCG Vaccine for Intradermal Injection Consumption Value Market Share by Region (2018-2029)
Figure 53. China BCG Vaccine for Intradermal Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan BCG Vaccine for Intradermal Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea BCG Vaccine for Intradermal Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India BCG Vaccine for Intradermal Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia BCG Vaccine for Intradermal Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia BCG Vaccine for Intradermal Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America BCG Vaccine for Intradermal Injection Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America BCG Vaccine for Intradermal Injection Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America BCG Vaccine for Intradermal Injection Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America BCG Vaccine for Intradermal Injection Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil BCG Vaccine for Intradermal Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina BCG Vaccine for Intradermal Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa BCG Vaccine for Intradermal Injection Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa BCG Vaccine for Intradermal Injection Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa BCG Vaccine for Intradermal Injection Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa BCG Vaccine for Intradermal Injection Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey BCG Vaccine for Intradermal Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt BCG Vaccine for Intradermal Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia BCG Vaccine for Intradermal Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa BCG Vaccine for Intradermal Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. BCG Vaccine for Intradermal Injection Market Drivers
Figure 74. BCG Vaccine for Intradermal Injection Market Restraints
Figure 75. BCG Vaccine for Intradermal Injection Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of BCG Vaccine for Intradermal Injection in 2022
Figure 78. Manufacturing Process Analysis of BCG Vaccine for Intradermal Injection
Figure 79. BCG Vaccine for Intradermal Injection Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source


More Publications